New catheter device tested for stubborn leg vein blockages

NCT ID NCT07529756

Not yet recruiting Knowledge-focused Sponsor: Intervene, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 04, 2026 · Updated 2 times

Summary

This observational study will track 87 people who are already scheduled to receive treatment with the Recana Thrombectomy Catheter System for blocked veins in their legs. The goal is to see how safe the device is and how well it works at clearing the blockages during the procedure. Participants will be followed for one year to monitor for any major complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Recana Thrombectomy Catheter System
What this could lead to: If successful, this registry could show that the Recana device is a safe and effective tool for clearing blocked veins in the legs, potentially improving blood flow and reducing symptoms.
What could go wrong: This is an early observational study with only 87 participants, not a randomized trial. It cannot prove the device works better than other treatments, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC VENOUS DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Bites and Stings chronic venous insufficiency coronary restenosis cortical blindness Embolism Embolism and Thrombosis thrombophilia due to thrombin defect thrombotic disease venous thromboembolism Venous Thrombosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC VENOUS DISEASE CHRONIC VENOUS INSUFFICIENCY (CVI) EMBOLISM AND THROMBOSIS THROMBECTOMY THROMBOSIS (STENT THROMBOSIS) THROMBOSIS, VENOUS VENOUS THROMBOSIS

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.